middle.news
AdAlta Advances EW-001 Toward Australian Clinical Trials
8:24am on Monday 5th of October, 2026 AEDT
•
Biotechnology
Read Story
AdAlta Advances EW-001 Toward Australian Clinical Trials
8:24am on Monday 5th of October, 2026 AEDT
Key Points
FDA pre-IND briefing pack submitted on schedule
Manufacturing technology transfer approved for Melbourne partner Cell Therapies
Pre-IND meeting scheduled for 3 November US time
Two Chinese study patients remain under formal follow-up
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE